Table 5

Mean percent change in confidence of diagnosis from baseline (per-protocol population)

Suspected diagnosis* at Visit 1nDaTscan (N=102)
Visit 1Visit 2 (4 weeks)Visit 3 (12 weeks)Visit 4 (1 year)
Observed mean (SD)Observed mean (SD)% change mean (SD)Observed mean (SD)% change mean (SD)Observed mean (SD)% change mean (SD)
Parkinsonian syndrome6972.6 (9.42)87.3 (13.21)21.7 (22.27)88.6 (11.41)23.6 (20.34)90.1 (10.87)26.1 (21.70)
Non-parkinsonian syndrome2279.1 (9.71)90.9 (11.92)16.6 (19.73)90.7 (12.18)16.0 (17.84)93.2 (11.19)19.7 (20.68)
Inconclusive1150.0 (0.00)80.9 (15.62)61.8 (31.25)83.2 (19.27)66.4 (38.54)80.9 (21.19)61.8 (42.38)
Control (N=113)
Parkinsonian syndrome7672.6 (9.22)73.5 (10.11)1.4 (8.65)75.0 (11.12)3.5 (11.15)77.2 (11.00)7.0 (14.61)
Non-parkinsonian syndrome2478.1 (9.65)75.2 (12.38)−3.8 (9.65)77.3 (10.73)−1.2 (4.04)77.1 (11.12)−0.9 (12.72)
Inconclusive1350.8 (2.77)53.1 (11.09)4.9 (23.04)50.0 (0.00)−1.3 (4.63)61.5 (18.19)21.8 (37.53)
Visit 2 vs Visit 1Visit 3 vs Visit 1Visit 4 vs Visit 1
Parkinsonian syndromep<0.001p<0.001p<0.001
Non-parkinsonian syndromep<0.001p<0.001p<0.001
  • Data on changes in confidence of diagnosis was not cumulative.

  • * Patients may have more than one clinical diagnosis.

  • One-sided t-test comparing percent change from baseline in confidence of diagnosis between treatment groups for each visit.

  • N, number of patients in each treatment group in the per-protocol population; PS, parkinsonian syndrome.